New medicine and its use

• 收藏
• 分享

专利权人:

ロコン ファーマ エービー

发明人:

ロスコグ，アンジェリカ,ロスコグ,アンジェリカ

申请号：

JP2017504257

公开号：

JP6524208B2

申请日:

2015.04.07

申请国别(地区):

JP

年份:

2019

代理人:

摘要：

The invention provides a novel compounds derived from CD154, but without the intracellular domain. Notably, the invention provides TMZ-CD154 and a method to treat diseases in which the novel molecule TMZ-CD154 is used. In particular, TMZ-CD154 is used to modify the immune responses in patients with immune related diseases such as cancer and infectious disease. The invention also relates to a method to activate cells with the TMZ-CD154 in vitro either prior to using the activated cells for therapy or for diagnostic purposes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/